AMP 2022 video: Immunexpress CEO describes rapid molecular test for sepsis
Latest in Point-of-Care Testing
FDA LDT oversight battle: Are we close?
March 6, 2024
Quest Diagnostics seeks to get a jump on PFAS testing in communities
February 13, 2024
Roche signs $350M deal to buy POC technology from LumiraDx
January 3, 2024